This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

NPS Pharmaceuticals Inc (NPSP)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 51.20M 17.47M 82.40M 77.17M
Receivables 41.24M 30.28M 29.53M 26.72M
Inventories 30.04M 0.00 0.00 0.00
Other Current Assets 1.38M 6.06M 7.86M 504.00K
Total Current Assets 258.75M 137.05M 199.63M 215.90M
Property, Plant & Equipment, Gross 7.76M 6.39M 5.46M 1.79M
Accumulated Depreciation & Depletion 3.36M 2.20M 1.11M 652.00K
Property, Plant & Equipment, Net 4.40M 4.19M 4.35M 1.14M
Intangibles 19.30M 0.00 0.00 0.00
Other Non-Current Assets 338.00K 436.00K 577.00K 2.44M
Total Non-Current Assets 33.47M 14.06M 14.35M 13.01M
Liabilities & Shareholder Equity
Total Assets 292.22M 151.11M 213.98M 228.90M
Accounts Payable 10.92M 4.37M 5.34M 3.58M
Short Term Debt 8.75M 6.28M 19.27M 55.84M
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 58.41M 29.57M 43.60M 82.14M
Long Term Debt 123.64M 169.57M 208.63M 294.26M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 5.28M 6.61M 7.86M 7.78M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 128.92M 176.18M 216.49M 302.04M
Total Liabilities 187.33M 205.75M 260.10M 384.18M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 104.89M -54.64M -46.12M -155.28M
Common Par 103.00K 87.00K 86.00K 67.00K
Additional Paid In Capital 1.13B 954.45M 944.34M 798.84M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.02B -1.01B -990.45M -954.18M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 56.00K 5.00K -96.00K 1.00K
Total Capitalization 228.52M 114.93M 162.51M 138.98M
Total Equity 104.89M -54.64M -46.12M -155.28M
Total Liabilities & Stock Equity 292.22M 151.11M 213.98M 228.90M
Total Common Shares Outstanding 102.61M 86.78M 86.08M 66.99M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 97.75M 87.00M 81.28M 58.61M
Diluted Weighted Shares Outstanding 97.75M 87.00M 81.28M 58.61M
Number of Employees 207 149 86 63
Number of Part-Time Employees 0 0 0 0
NPSP News

NPSP NPS Pharmaceuticals Inc

Analysts Ratings for NPSP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 8 8 6
Moderate Buy 1 1 1 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET NPSP ANALYST REPORT

Brokerage Partners

NPSP Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs